Spectral Genomics Overview
- Founded
-
2000
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$14M
Spectral Genomics General Information
Description
Developer and marketer of products and services in molecular genetics and diagnostics. The company also provides genomic profiling services for customers in academic and industrial research laboratories.
Contact Information
Website
www.spectralgenomics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- 8080 North Stadium Drive
- Suite 2200
- Houston, TX 77054
- United States
+1 (713) 000-0000
Spectral Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 01-Apr-2006 | $14M | 000.00 | 0000 | Completed | Clinical Trials - Phase 3 |
| 4. Early Stage VC (Series B) | 15-Mar-2004 | 00.00 | 000.00 | Completed | Clinical Trials - Phase 3 | |
| 3. Early Stage VC (Series A) | 01-Aug-2001 | 000 | 000 | Completed | Product Development | |
| 2. Accelerator/Incubator | Completed | Product Development | ||||
| 1. Spin-Off | 01-Feb-2000 | Completed | Product Development |
Spectral Genomics Patents
Spectral Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2003220159-A8 | Articles of manufacture and methods for making hydrophobic derivatized arrays | Inactive | 08-Mar-2002 | 0000000000 | |
| AU-2003220159-A1 | Articles of manufacture and methods for making hydrophobic derivatized arrays | Inactive | 08-Mar-2002 | 0000000000 | |
| AU-2002365101-A1 | Articles of manufacture and methods for examining biochips using phase contrast optics | Inactive | 28-Dec-2001 | 000000000 | |
| AU-2002331777-A1 | Arrays comprising pre-labeled biological molecules and methods for making and using these arrays | Inactive | 30-Aug-2001 | 0000000000 | |
| JP-2005500023-A | Compositions and methods for performing arrayed genomic nucleic acid analysis of biomolecules | Pending | 10-May-2001 | B82Y30/00 |
Spectral Genomics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Robert Johnson Ph.D | President & Chief Operating Officer |
Spectral Genomics Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BCM Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Baylor College Of Medicine | Corporation | Minority | 000 0000 | 000000 0 | |
| BioTex Finance | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Burrill & Co | Merchant Banking Firm | Minority | 000 0000 | 000000 0 | |
| Houston Technology Center | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
Spectral Genomics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 15-Mar-2004 | 0000000000 | Biotechnology | 000000 00 |
Spectral Genomics Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000000 00000000 | 15-Mar-2004 | 000000000000000000 | Completed |
|